Vitamin K

Sharing for a healthy society.

Vitamin K is a vitamin found in leafy green vegetables, broccoli, and Brussels sprouts. The name vitamin K comes from the German word “Koagulationsvitamin.”

Several forms of vitamin K are used around the world as medicine. Vitamin K1 (phytonadione) and vitamin K2 (menaquinone) are available in North America. Vitamin K1 is generally the preferred form of vitamin K because it is less toxic and works faster for certain conditions.

Vitamin K is most commonly used for blood clotting problems or for reversing the blood-thinning effects of warfarin. It is also used for many other conditions, but there is no good scientific evidence to support most of these other uses. 

Working

Vitamin K is an essential vitamin that is needed by the body for blood clotting and other important processes.

Uses & Effectiveness

Effective for

  • Bleeding problems in newborns with low levels of vitamin K (hemorrhagic disease). Giving vitamin K1 by mouth or as a shot into the muscle helps prevent bleeding problems in newborns. Shots seem to work the best.
  • Low levels of the blood-clotting protein prothrombin (hypoprothrombinemia). Taking vitamin K1 by mouth or as an injection into the vein can prevent and treat bleeding problems in people with low levels of prothrombin due to using certain medications.
  • A rare inherited bleeding disorder (vitamin K-dependent clotting factors deficiency or VKCFD). Taking vitamin K by mouth or as an injection into the vein can help prevent bleeding in people with VKCFD.
  • Reversing the blood-thinning effects of warfarin. Taking vitamin K1 by mouth or as in injection into the vein can reverse too much blood thinning caused by warfarin. However, injecting vitamin K1 under the skin does not seem to work. Taking vitamin K along with warfarin also seems to help stabilize blood clotting time in people taking warfarin. It works best in people who have low vitamin K levels.

Possibly Effective for

  • Weak and brittle bones (osteoporosis). Taking a specific form of vitamin K2 seems to improve bone strength and reduce the risk of fracture in most older women with weak bones. But it doesn’t seem to benefit older women who still have strong bones. Taking vitamin K1 seems to increase bone strength and might prevent fractures in older women. But it might not work as well in older men. Vitamin K1 doesn’t seem to improve bone strength in women who have not gone through menopause or in people with Crohn’s disease.

Possibly Ineffective for

  • Bleeding into or around the fluid-filled areas (ventricles) of the brain (intraventricular hemorrhage). Giving vitamin K to women at risk for very preterm births does not seem to prevent bleeding in the brain of preterm infants. It also doesn’t seem to reduce the risk of nerve injury caused by these bleeds.

Insufficient Evidence for

  • Athletic performance. Early research suggests that taking vitamin K2 by mouth might improve exercise performance by increasing the work of the heart.
  • A blood disorder that reduces levels of protein in the blood called hemoglobin (beta-thalassemia). Early research shows that taking vitamin K2 by mouth along with calcium and vitamin D can improve bone mass in children with this blood disorder.
  • Breast cancer. Research suggests that higher dietary intake of vitamin K2 is linked with a lower risk of developing breast cancer.
  • Cancer. Some research has linked a higher food intake of vitamin K2, but not vitamin K1, with a reduced risk of death from cancer. But other research has linked a higher food intake of vitamin K1, but not vitamin K2, with a reduced risk of death from cancer.
  • Cataracts. Some research has linked a higher food intake of vitamin K2 with a lower risk of getting cataracts.
  • Colon cancer, rectal cancer. Early research suggests that a higher dietary intake of vitamin K is not linked with a reduced risk of cancer of the colon and rectum.
  • Heart disease. Higher dietary intake of vitamin K2 has been linked with a reduced risk of heart disease, risk factors for heart disease, and death due to heart disease in older men and women. But vitamin K2 intake from food does not seem to be linked with a reduced risk a heart disease in people at high risk for this condition. Dietary intake of vitamin K1 has not been linked with a reduced risk of heart disease. But increasing vitamin K1 intake from food has been linked with a reduced risk of death due to heart disease. Also, taking vitamin K1 as a supplement seems to prevent or reduce the advancement of coronary calcification. This is a risk factor for heart disease.
  • Cystic fibrosis. People with cystic fibrosis can have low levels of vitamin K due to problems digesting fat. Taking a combination of vitamins A, D, E, and K seem to improve vitamin K levels in people with cystic fibrosis who have trouble digesting fat. Also, early research shows that taking vitamin K by mouth can enhance the production of osteocalcin. Osteocalcin plays a role in the body’s bone-building and metabolic regulation. But there is no reliable evidence suggesting that vitamin K improves overall health in people with cystic fibrosis.
  • Depression. Early research suggests that a higher intake of vitamin K from food is linked with a lower risk for depression. But there isn’t any research on whether taking vitamin K supplements can reduce the risk of depression.
  • Diabetes. Early research shows that taking a multivitamin fortified with vitamin K1 does not lower the risk of developing diabetes compared to taking a regular multivitamin.
  • An acne-like rash caused by certain cancer drugs. People who are given a certain type of anticancer medicine often develop a skin rash. Early research shows that applying a cream containing vitamin K1 helps prevent skin rash in people being given this type of medicine.
  • High cholesterol. There is early evidence that vitamin K2 might lower cholesterol in people on dialysis with high cholesterol levels.
  • Liver cancer. Taking vitamin K2 does not seem to prevent liver cancer recurrence. But some early research shows that taking vitamin K2 reduces the risk of liver cancer in people with liver cirrhosis.
  • Lung cancer. Early research suggests that a higher intake of vitamin K2 from food is linked with a reduced risk of lung cancer and lung cancer-related death. Dietary intake of vitamin K1 does not seem to be linked with a reduced risk of these events.
  • Multiple sclerosis (MS). Interferon is a medicine that helps people with MS. This medicine often causes a rash and burning of the skin. Early research shows that applying vitamin K cream modestly reduces rash and burning in people treated with interferon.
  • Prostate cancer. Early research suggests that higher dietary intake of vitamin K2, but not vitamin K1, is linked with a reduced risk of prostate cancer.
  • Rheumatoid arthritis (RA). Early research shows that taking vitamin K2 along with arthritis medicine reduces markers of joint swelling better than taking arthritis medicine alone. But taking vitamin K1 does not seem to reduce symptoms of RA.
  • Stroke. Population research suggests that dietary intake of vitamin K1 is not linked with a reduced risk of stroke.
  • Bruises.
  • Burns.
  • Scars.
  • Spider veins.
  • Stretch marks.
  • Swelling.

Side Effects & Safety

When taken by mouth: The two forms of vitamin K (vitamin K1 and vitamin K2) are LIKELY SAFE for most people when taken appropriately. Most people do not experience any side effects when taking vitamin K in the recommended amount each day. However, some people may have an upset stomach or diarrhea.

When applied to the skin: Vitamin K1 is POSSIBLY SAFE for most people when applied as a cream that contains 0.1% vitamin K1.

When given by IV: The two forms of vitamin K (vitamin K1 and vitamin K2) are LIKELY SAFE for most people when injected into the vein appropriately.

Special Precautions & Warnings:

Pregnancy and breast-feeding: When taken in the recommended amount each day, vitamin K is LIKELY SAFE for pregnant and breastfeeding women. Don’t use higher amounts without the advice of your healthcare professional.

Children: The form of vitamin K known as vitamin K1 is LIKELY SAFE for children when taken by mouth or injected into the body appropriately.

Diabetes: The form of vitamin K known as vitamin K1 might lower blood sugar levels. If you have diabetes and take vitamin K1, monitor your blood sugar levels closely.

Kidney disease: Too much vitamin K can be harmful if you are receiving dialysis treatments due to kidney disease.

Liver disease: Vitamin K is not effective for treating clotting problems caused by severe liver disease. In fact, high doses of vitamin K can make clotting problems worse in these people.

Reduced bile secretion: People with decreased bile secretion who are taking vitamin K might need to take supplemental bile salts along with vitamin K to ensure vitamin K absorption.

Interactions

Major Interaction

Do not take this combination!

  • Warfarin (Coumadin) interacts with VITAMIN K: Vitamin K is used by the body to help blood clot. Warfarin (Coumadin) is used to slow blood clotting. By helping the blood clot, vitamin K might decrease the effectiveness of warfarin (Coumadin). Be sure to have your blood checked regularly. The dose of your warfarin (Coumadin) might need to be changed.

Dosing

The following doses have been studied in scientific research: 

ADULTS

BY MOUTH:

  • For weak and brittle bones (osteoporosis): The MK-4 form of vitamin K2 has been taken in doses of 45 mg daily. Also, vitamin K1 has been taken in doses of 1-10 mg daily.
  • For a rare, inherited bleeding disorder (vitamin K-dependent clotting factors deficiency or VKCFD): 10 mg of vitamin K has been taken 2-3 times weekly.
  • For reversing the blood-thinning effects of warfarin: A single dose of 1-5 mg of vitamin K1 is typically used to reverse the effects of taking too much warfarin. The exact dose needed is determined by a lab test called the INR. Daily doses of 100-200 micrograms of vitamin K have been used for people taking warfarin long-term who have unstable blood clotting.

WITH A NEEDLE:

  • For a rare, inherited bleeding disorder (vitamin K-dependent clotting factors deficiency or VKCFD): 10 mg of vitamin K has been injected into the vein. How often these injections are given is determined by a lab test called the INR.
  • For reversing the blood-thinning effects of warfarin: A single dose of 0.5-3 mg of vitamin K1 is typically used. The exact dose needed is determined by a lab test called the INR.

CHILDREN

BY MOUTH:

  • For bleeding problems in newborns with low levels of vitamin K (hemorrhagic disease): 1-2 mg of vitamin K1 has been given in three doses over 8 weeks. Also, single doses containing 1 mg of vitamin K1, 5 mg of vitamin K2, or 1-2 mg of vitamin K3 have been used.

WITH A NEEDLE:

  • For bleeding problems in newborns with low levels of vitamin K (hemorrhagic disease): 1 mg of vitamin K1 has been given as a shot into the muscle.

There isn’t enough scientific information to determine recommended dietary allowances (RDAs) for vitamin K, so daily adequate intake (AI) recommendations have been formed instead: The AIs are: infants 0-6 months, 2 mcg; infants 7-12 months, 2.5 mcg; children 1-3 years, 30 mcg; children 4-8 years, 55 mcg; children 9-13 years, 60 mcg; adolescents 14-18 years (including those who are pregnant or breast-feeding), 75 mcg; men over 19 years, 120 mcg; women over 19 years (including those who are pregnant and breastfeeding), 90 mcg.

Hope this article is Helpful 🙂 🙂

Sharing for a healthy society.

Leave a Reply

Your email address will not be published. Required fields are marked *

shares